GGrantIndex
Sort

3,198 grants matching mrna vaccine

RNA-Binding Proteins and Host Shut-Off by VSV

$435,587
Douglas S. Lyles · Wake Forest University Health Sciences · R01 · FY2016 · AI

Inhibitors of host kinases as molecular targets for immune defense against HIV-1

$435,416
Mathias Lichterfeld · Massachusetts General Hospital · R01 · FY2012 · AI

Mechanism Of Rotavirus Genome Replication And Packaging

$435,397
John Patton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Project 3: Demethylation of HPV-associated head and neck cancer to trigger APOBEC synthetic lethality and enhance immune response

$435,036
Karen S Anderson · Yale University · P50 · FY2022 · DE

Cellular Immunity to JC Virus in AIDS-Associated Progressive Multifocal Leukoence

$435,000
Igor J Koralnik · Beth Israel Deaconess Medical Center · R56 · FY2010 · NS

Inhibitors of host kinases as molecular targets for immune defense against HIV-1

$435,000
Mathias Lichterfeld · Massachusetts General Hospital · R01 · FY2014 · AI

Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas

$434,992
Elias Sayour · University Of Florida · R37 · FY2023 · CA

RNA-Binding Proteins and Host Shut-Off by VSV

$434,651
Douglas S. Lyles · Wake Forest University Health Sciences · R01 · FY2015 · AI

Cross-Species transmission and adaptation of primate lentiviruses

$433,750
Welkin E Johnson · Harvard Medical School · R01 · FY2009 · AI

Modeling of Lung HIV Cytokine/Chemokine Networks

$433,668
Boston Medical Center · R01 · FY2004 · HL

Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma

$433,378
Marc Ladanyi · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA

Development of mosaic enterovirus mRNA vaccine to prevent hand, foot and mouth disease

$433,175
Todd Christopher Bradley · Children'S Mercy Hosp (Kansas City, Mo) · R21 · FY2025 · AI

Recent Thymic Emigrants of the CD4 T-cell Lineage

$433,163
David Bram Lewis · Stanford University · R01 · FY2011 · AI

How Does 3' UTR Secondary Structure Program mRNA Transport in Myelination?

$432,982
John B Zuchero · Stanford University · R21 · FY2021 · NS

Project 3: Demethylation of HPV-associated head and neck cancer to trigger APOBEC synthetic lethality and enhance immune response

$432,279
Karen S Anderson · Yale University · P50 · FY2024 · DE

RNA-Binding Proteins and Host Shut-Off by VSV

$431,840
Douglas S. Lyles · Wake Forest University Health Sciences · R01 · FY2014 · AI

Listeria Hemolysin and Escape from a Vacuole

$431,791
Daniel A Portnoy · University Of California Berkeley · R01 · FY2010 · AI

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

$431,130
Edward Chu · Albert Einstein College Of Medicine · P30 · FY2022 · CA

Synthetic Studies Related to Cancer Research/Treatment

$430,815
Paul Wender · Stanford University · R01 · FY2023 · CA

Role of RNA helicase DDX1 in influenza A virus replication

$430,721
Yuchun Du · University Of Arkansas At Fayetteville · R15 · FY2022 · AI

Synthetic Studies Related to Cancer Research/Treatment

$430,697
Paul Wender · Stanford University · R01 · FY2025 · CA

Molecular Genetics of Rhizobium Nodulation Plasmids

$430,528
Graham C Walker · Massachusetts Institute Of Technology · R01 · FY2011 · GM

Molecular Genetics of Rhizobium Nodulation Plasmids

$430,387
Graham C Walker · Massachusetts Institute Of Technology · R01 · FY2012 · GM

Immune cell control of ovarian cancer

$430,385
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Manipulating nucleic acids: applications in RNA biosensing, single-molecule analysis, and DNA nanotechnology

$430,375
Ken A Halvorsen · State University Of New York At Albany · R35 · FY2025 · GM